Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breathe easy: yoga breathing may ease COPD stress

NCT ID NCT06404008

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a 15-minute controlled breathing routine (REST) in 20 adults with COPD who reported high stress. Participants learned three yoga breathing techniques and practiced them twice daily for a week with remote guidance. The study aimed to see if the routine was feasible and acceptable, and measured changes in stress and breathlessness. Because it's a small early trial, results are preliminary and not yet proof of effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
controlled breathing protocol (yoga breathing techniques)
What this could lead to
If it works, this could offer a simple, drug-free way to help COPD patients manage stress and breathlessness at home.
What could go wrong
This is a very small pilot trial with only 20 participants, so results may not apply to everyone. It tests feasibility, not effectiveness, and relies on self-reported measures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Jul 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of spirometry confirmed COPD (FEV1/FVC \<0.70 + FEV1\<80%) * Perceived Stress Scale \> 13 * Age \>40 years old * Able to read, write, and speak in English * Able to attend 1 in person training session and 1 in person trial sessions Exclusion Criteria: * Current regular practice of breathing exercises or pranayama * No access to internet or telephone * Recent hospitalization for COPD exacerbation or any reason in the past 30 days * Other primary lung disease (ILD, asthma, bronchiectasis) by self-report or chart review * Non-correctable hearing impairment (i.e. hearing impairment despite hearing aids) * Severe cognitive impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ascension Seton Medical Center

    Austin, Texas, 78705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.